SEC CIK 1891900
Teehan Brendan
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| PCRXview stock → | 100,934.268 | 2026-02-11 |
| ACADview stock → | 62,105 | 2024-11-19 |
Position History — ACAD
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — ACAD
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2024-11-19 | Open-market sale | 10,329 | $16.81 | 62,105 |
| 2024-11-17 | Option exercise (derivative) | 9,913 | $0.00 | 9,913 |
| 2024-11-17 | Option exercise | 9,913 | — | 62,521 |
| 2024-11-17 | Option exercise | 9,913 | — | 72,434 |
| 2024-08-19 | Open-market sale | 9,534 | $15.28 | 52,177 |
| 2024-08-16 | Grant / award | 13,629 | $0.00 | 61,711 |
| 2024-08-16 | Grant / award | 5,024 | $0.00 | 48,082 |
| 2024-05-02 | Open-market sale | 3,477 | $16.94 | 42,133 |
| 2024-05-01 | Option exercise (derivative) | 6,814 | $0.00 | 20,445 |
| 2024-05-01 | Option exercise | 6,814 | — | 45,610 |
| 2024-04-08 | Open-market sale | 2,568 | $17.87 | 38,796 |
| 2024-04-05 | Option exercise (derivative) | 5,024 | $0.00 | 10,048 |
| 2024-04-05 | Option exercise | 5,024 | — | 41,364 |
| 2024-03-27 | Open-market sale | 5,140 | $17.90 | 36,340 |
| 2024-03-25 | Grant / award (derivative) | 27,460 | $0.00 | 27,460 |
| 2024-03-25 | Grant / award (derivative) | 89,516 | $0.00 | 89,516 |
| 2024-03-25 | Grant / award | 10,048 | $0.00 | 41,480 |
| 2024-02-26 | Open-market sale | 624 | $24.67 | 31,432 |
| 2024-02-23 | Option exercise (derivative) | 1,107 | $0.00 | 1,107 |
| 2024-02-23 | Option exercise | 1,107 | — | 32,056 |
| 2024-01-08 | Open-market sale | 731 | $29.96 | 30,949 |
| 2024-01-06 | Option exercise (derivative) | 1,287 | $0.00 | 0 |
| 2024-01-06 | Option exercise | 1,287 | — | 31,680 |
| 2023-11-20 | Open-market sale | 4,960 | $22.64 | 30,393 |
| 2023-11-17 | Option exercise (derivative) | 4,956 | $0.00 | 19,826 |
| 2023-11-17 | Option exercise | 4,956 | — | 35,353 |
| 2023-11-17 | Option exercise | 4,956 | — | 30,397 |
| 2023-05-17 | Option exercise (derivative) | 14,869 | $0.00 | 24,782 |
| 2023-05-17 | Open-market sale | 14,869 | $22.50 | 24,356 |
| 2023-05-17 | Option exercise | 14,869 | — | 24,356 |
| 2023-05-17 | Option exercise | 14,869 | — | 39,225 |
| 2023-05-01 | Open-market sale | 548 | $21.18 | 9,487 |
| 2023-05-01 | Grant / award (derivative) | 89,936 | $0.00 | 89,936 |
| 2023-05-01 | Grant / award (derivative) | 27,259 | $0.00 | 27,259 |
| 2023-04-29 | Option exercise (derivative) | 1,567 | $0.00 | 0 |
| 2023-04-29 | Option exercise | 1,567 | $0.00 | 10,035 |
| 2023-04-06 | Open-market sale | 1,751 | $18.16 | 8,468 |
| 2023-04-05 | Option exercise (derivative) | 5,024 | $0.00 | 15,072 |
| 2023-04-05 | Option exercise | 5,024 | — | 10,219 |
| 2023-02-24 | Open-market sale | 461 | $18.78 | 5,195 |
| 2023-02-23 | Option exercise (derivative) | 1,107 | $0.00 | 2,214 |
| 2023-02-23 | Option exercise | 1,107 | — | 5,656 |
| 2023-01-09 | Open-market sale | 532 | $17.13 | 4,549 |
| 2023-01-06 | Option exercise (derivative) | 1,286 | $0.00 | 1,287 |
| 2023-01-06 | Option exercise | 1,286 | — | 5,081 |
| 2022-05-02 | Open-market sale | 552 | $18.18 | 3,437 |
| 2022-04-29 | Option exercise (derivative) | 1,567 | $0.00 | 1,567 |
| 2022-04-29 | Option exercise | 1,567 | — | 3,989 |
| 2022-04-05 | Grant / award (derivative) | 20,096 | $0.00 | 20,096 |
| 2022-04-05 | Grant / award (derivative) | 68,966 | $0.00 | 68,966 |
| 2022-02-23 | Option exercise (derivative) | 1,106 | $0.00 | 3,321 |
| 2022-02-23 | Option exercise | 1,106 | $0.00 | 2,894 |
| 2022-02-23 | Open-market sale | 472 | $23.80 | 2,422 |
| 2022-01-06 | Option exercise (derivative) | 1,286 | $0.00 | 2,573 |
| 2022-01-06 | Option exercise | 1,286 | — | 2,326 |
| 2022-01-06 | Open-market sale | 538 | $23.05 | 1,788 |
| 2022-01-06 | Option exercise (derivative) | 1,286 | $0.00 | 2,573 |
| 2021-11-17 | Grant / award (derivative) | 39,651 | $0.00 | 39,651 |
| 2021-11-01 | — | — | — | 807 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.